KALA BIO, Inc. (KALA)
NASDAQ·Healthcare·Biotechnology
$0.11
-4.44%
Mkt Cap $5.69M
Analyst Ratings
No recent rating data.
Price Target (5 analysts)
$1.50
Range $1.50 – $1.50
Implied Upside
+1214.6%
Consensus $1.50 vs current $0.11
NASDAQ·Healthcare·Biotechnology
$0.11
-4.44%
Mkt Cap $5.69M
No recent rating data.
Price Target (5 analysts)
$1.50
Range $1.50 – $1.50
+1214.6%
Consensus $1.50 vs current $0.11